Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
Phosphodiesterase (PDE) inhibitors prevent the hydrolysis of cyclic nucleotides, second messengers of many receptors. The PDE superfamily comprises 11 families, PDE1 to PDE11, which differ in substrate preference, regulation and tissue distribution. Some families hydrolyze cyclic adenosine monophosphate (cAMP), others cyclic guanosine monophosphate (cGMP), and several act on both. By controlling the amplitude and location of these signals, PDEs shape inflammation, smooth muscle tone and cardiac function. PDE4 inhibitors in this category include roflumilast and apremilast, which are studied in inflammatory cell signaling. Sildenafil inhibits the cGMP-specific PDE5, and cilostazol is a PDE3 inhibitor. Ibudilast inhibits several families, including PDE3, PDE4, PDE10 and PDE11.
PDEδ-IN-1 is a selective ligand of phosphodiesterase delta (PDEδ), primarily involved in regulating intracellular signaling pathways. This compound is utilized in research focused on PDEδ-related cellular processes and can be employed to synthesize PDEδ autophagic degrader 1. Its ability to modulate PDEδ function makes it a valuable tool for elucidating the role of this enzyme in various biological contexts.
Out of stock
All 3 sizes